Global Castration-resistant Prostate Cancer Treatment Market is Estimated at a Record USD 19.35 Billion by the End of 2030 | Infinium Global Research

Infinium Global Research unveils an expansive report, delving deep into the global and regional Castration-resistant Prostate Cancer Treatment Market, featuring comprehensive analysis of segments, sub-segments, drivers, and future market trends.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/429

Market Insight:

The global castration-resistant prostate cancer treatment market, valued at USD 10.11 billion in 2022, is poised to escalate to USD 19.35 billion by 2030, reflecting a substantial CAGR of 8.51% during the forecast period 2023-2030. This market segment crucially addresses the pressing need for advanced therapies dedicated to combating advanced prostate cancer that has resisted conventional hormone treatments.

Market Dynamics:

The market growth is propelled by the introduction of novel treatments, including targeted therapies and immunotherapies, offering advanced solutions for patients and expanding opportunities for pharmaceutical companies. The escalating prevalence of castration-resistant prostate cancer among the aging population significantly contributes to the growing demand for effective treatments. However, high treatment costs pose challenges to widespread adoption, although advancements in precision medicine offer a promising landscape for the market.

Regional Insights:

North America is expected to dominate the market, driven by high disease prevalence, substantial investments in research and development by major market players, and favorable reimbursement policies. The region's focus on healthcare innovation further bolsters its optimistic market outlook. Conversely, the Asia Pacific region anticipates the highest growth rate, attributed to expanding healthcare infrastructure, increased research and development investments, and the presence of leading oncology companies. These developments position the Asia Pacific as a promising hub for advancements in treating castration-resistant prostate cancer.

Segmentation:

The report encompasses therapy types such as chemotherapy, hormonal therapy, immunotherapy, and radiotherapy, along with drug delivery methods including oral and injectable routes. Additionally, it covers distribution channels including hospital pharmacies, retail pharmacies, and online pharmacies.

Featured Companies:

Profiles of key market players like Pfizer Inc., Astellas Pharma Inc., Johnson & Johnson, and others provide insights into their contributions and strategies within the castration-resistant prostate cancer treatment market.

The Infinium Global Research report on castration-resistant prostate cancer treatment offers stakeholders essential insights into this critical healthcare sector, aiding in navigating its evolving dynamics.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/429

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Castration-resistant Prostate Cancer Treatment Market Highlights

2.2. Castration-resistant Prostate Cancer Treatment Market Projection

2.3. Castration-resistant Prostate Cancer Treatment Market Regional Highlights

Chapter 3. Global Castration-resistant Prostate Cancer Treatment Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Therapy Type

3.4.2. IGR-Growth Matrix Analysis by Drug Delivery Method

3.4.3. IGR-Growth Matrix Analysis by Distribution Channel

3.4.4. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Castration-resistant Prostate Cancer Treatment Market

Chapter 4. Castration-resistant Prostate Cancer Treatment Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Castration-resistant Prostate Cancer Treatment Market

5.2. Companies Profiles

5.2.1. Pfizer Inc.

5.2.2. Astellas Pharma Inc.

5.2.3. Johnson & Johnson, Inc.

5.2.4. Sanofi

5.2.5. Novartis AG

5.2.6. Bayer AG

5.2.7. GSK plc.

5.2.8. Northwest Biotherapeutics, Inc

5.2.9. Active Biotech AB

5.2.10. Dendreon Pharmaceuticals LLC.

Chapter 6. Global Castration-resistant Prostate Cancer Treatment Market by Therapy Type

6.1. Chemotherapy

6.2. Hormonal Therapy

6.3. Immunotherapy

6.4. Radiotherapy

Chapter 7. Global Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

7.1. Oral Route

7.2. Injectable Route

Chapter 8. Global Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

8.1. Hospital Pharmacies

8.2. Retail Pharmacies

8.3. Online Pharmacies

Chapter 9. Global Castration-resistant Prostate Cancer Treatment Market by Region 2023-2030

9.1. North America

9.1.1. North America Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.1.2. North America Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.1.3. North America Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.1.4. North America Castration-resistant Prostate Cancer Treatment Market by Country

9.1.4.1. The U.S. Castration-resistant Prostate Cancer Treatment Market

9.1.4.1.1. The U.S. Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.1.4.1.2. The U.S. Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.1.4.1.3. The U.S. Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.1.4.2. Canada Castration-resistant Prostate Cancer Treatment Market

9.1.4.2.1. Canada Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.1.4.2.2. Canada Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.1.4.2.3. Canada Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.1.4.3. Mexico Castration-resistant Prostate Cancer Treatment Market

9.1.4.3.1. Mexico Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.1.4.3.2. Mexico Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.1.4.3.3. Mexico Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.2. Europe

9.2.1. Europe Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.2.2. Europe Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.2.3. Europe Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.2.4. Europe Castration-resistant Prostate Cancer Treatment Market by Country

9.2.4.1. Germany Castration-resistant Prostate Cancer Treatment Market

9.2.4.1.1. Germany Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.2.4.1.2. Germany Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.2.4.1.3. Germany Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.2.4.2. United Kingdom Castration-resistant Prostate Cancer Treatment Market

9.2.4.2.1. United Kingdom Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.2.4.2.2. United Kingdom Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.2.4.2.3. United Kingdom Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.2.4.3. France Castration-resistant Prostate Cancer Treatment Market

9.2.4.3.1. France Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.2.4.3.2. France Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.2.4.3.3. France Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.2.4.4. Italy Castration-resistant Prostate Cancer Treatment Market

9.2.4.4.1. Italy Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.2.4.4.2. Italy Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.2.4.4.3. Italy Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.2.4.5. Rest of Europe Castration-resistant Prostate Cancer Treatment Market

9.2.4.5.1. Rest of Europe Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.2.4.5.2. Rest of Europe Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.2.4.5.3. Rest of Europe Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.3. Asia Pacific

9.3.1. Asia Pacific Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.3.2. Asia Pacific Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.3.3. Asia Pacific Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.3.4. Asia Pacific Castration-resistant Prostate Cancer Treatment Market by Country

9.3.4.1. China Castration-resistant Prostate Cancer Treatment Market

9.3.4.1.1. China Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.3.4.1.2. China Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.3.4.1.3. China Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.3.4.2. Japan Castration-resistant Prostate Cancer Treatment Market

9.3.4.2.1. Japan Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.3.4.2.2. Japan Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.3.4.2.3. Japan Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.3.4.3. India Castration-resistant Prostate Cancer Treatment Market

9.3.4.3.1. India Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.3.4.3.2. India Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.3.4.3.3. India Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.3.4.4. South Korea Castration-resistant Prostate Cancer Treatment Market

9.3.4.4.1. South Korea Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.3.4.4.2. South Korea Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.3.4.4.3. South Korea Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.3.4.5. Australia Castration-resistant Prostate Cancer Treatment Market

9.3.4.5.1. Australia Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.3.4.5.2. Australia Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.3.4.5.3. Australia Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.3.4.6. Rest of Asia-Pacific Castration-resistant Prostate Cancer Treatment Market

9.3.4.6.1. Rest of Asia-Pacific Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.3.4.6.2. Rest of Asia-Pacific Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.3.4.6.3. Rest of Asia-Pacific Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.4. RoW

9.4.1. RoW Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.4.2. RoW Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.4.3. RoW Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.4.4. RoW Castration-resistant Prostate Cancer Treatment Market by Sub-region

9.4.4.1. Latin America Castration-resistant Prostate Cancer Treatment Market

9.4.4.1.1. Latin America Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.4.4.1.2. Latin America Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.4.4.1.3. Latin America Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.4.4.2. Middle East Castration-resistant Prostate Cancer Treatment Market

9.4.4.2.1. Middle East Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.4.4.2.2. Middle East Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.4.4.2.3. Middle East Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

9.4.4.3. Africa Castration-resistant Prostate Cancer Treatment Market

9.4.4.3.1. Africa Castration-resistant Prostate Cancer Treatment Market by Therapy Type

9.4.4.3.2. Africa Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method

9.4.4.3.3. Africa Castration-resistant Prostate Cancer Treatment Market by Distribution Channel

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/429

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of castration-resistant prostate cancer treatment.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.